Mon4t

Country:
Israel
Founding year:
2017

Mon4t develops software that transforms standard smartphones into tools for remote neurological assessment. The company’s platform uses built-in smartphone sensors and cameras to capture data related to motor function, cognition, and affective state. Its approach focuses on enabling accessible, at-home monitoring without specialized hardware. Mon4t positions its technology within clinical research and digital health contexts.

The technology leverages smartphone-based inputs such as video, touch interaction, and motion data to assess neurological performance. AI-driven models analyze these signals to extract quantitative measures of movement, reaction, and behavioral patterns. By standardizing test protocols on widely available devices, the system enables frequent and repeatable assessments. This approach emphasizes scalability and low patient burden compared to clinic-based testing.

Mon4t targets applications in remote monitoring for neurological conditions, clinical trials, and longitudinal patient follow-up. The platform is intended to support clinicians and researchers by extending assessment beyond in-person visits. Its positioning reflects broader efforts to decentralize neurological evaluation through software-based diagnostics and monitoring tools.

Tools and Infrastructure
Decision Support
Monitoring

Neurofounders Insights

Modality:
Biomarkers
Form Factor:
Software/app
Interface Depth:
Software
Indication:
Parkinson's
Target user:
Clinicians
Regulatory stage:
FDA cleared (501k)

Unknown

Mon4t turns commodity smartphones into neurological assessment devices, making it a software-first digital biomarker platform for remote monitoring of motor and cognitive status. Its strongest advantage is accessibility and low deployment friction, though this also lowers barriers to imitation.

Related companies

Articles featuring

Mon4t

Press releases

No press releases published yet.